Lavipharm Group posted higher financial results on consolidated sales as well as consolidated earnings before taxes and after minority interests level in the third quarter of the year.
Specifically, consolidated earnings before taxes and after minority interests increased by 21.8 percent to 4.7 million Euro compared with 3.9 million Euro in the corresponding period of 2001. Consolidated own sales reached 160 million Euro compared to 141.5 million at the corresponding period of 2001, an increas...
This story is part of New Europe's Premium content.
|To Read the Full Story, Subscribe or Sign In from the ↑ Top of the Page ↑|